Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients

Affiliations

• ¹ Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
• ² Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ³ Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁴ Department of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁵ Private Neurological Practice, Hamburg, Germany.
• ⁶ Institute of Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁷ German Center for Infection Disease (DZIF), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ⁸ Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [email protected].
• ⁹ German Center for Infection Disease (DZIF), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [email protected].
• ¹⁰ Institute of Neuroimmunology and Multiple Sclerosis (INIMS), Center for Molecular Neurobiology Hamburg (ZMNH), University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. [email protected].